Shuttle Pharmaceuticals receives Nasdaq delisting notice for late Q2 Form 10-Q

Shuttle Pharmaceuticals Holdings, Inc.

Nasdaq notice received Aug 28, 2026 for non-compliance with Listing Rule 5250(c)(1) due to delayed Form 10-Q for quarter ended June 30, 2026.
Company must submit compliance plan by Oct 27, 2026; Nasdaq may grant exception until Feb 22, 2027.
No immediate delisting; non-compliance indicator broadcast starting approx. Sept 4, 2026.
Failure to regain compliance would subject common stock to delisting from Nasdaq; stock continues trading on Nasdaq.
Company intends to file Form 10-Q as soon as practicable; cites completion of accounting firm review procedures as a factor.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.